Skip to main content
. Author manuscript; available in PMC: 2017 Sep 11.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):90–98. doi: 10.1097/QAI.0b013e31825bd9b7

TABLE 1.

Characteristics of 790 Children Initiating HIV Care Between December 2004 and May 2010 in Kinshasa, DRC

Baseline*
 Median age, years (IQR) 5.9 (2.7–9.8)
 Age [n (%)]
  <1 63 (8.0)
  1–4 277 (35.1)
  5–9 265 (33.5)
  10–17 185 (23.4)
 Female sex [n (%)] 415 (52.5)
 WHO HIV clinical stage [n (%)]
  1 153 (19.4)
  2 232 (29.4)
  3 369 (46.7)
  4 36 (4.6)
 Median CD4 percentage (IQR) 15 (9–22)
 WHO age-specific severity of immunodeficiency [n (%)]
  Not significant 174 (22.0)
  Mild 88 (11.1)
  Advanced 76 (9.6)
  Severe 452 (57.2)
 Started cotrimoxazole at first visit [n (%)] 726 (91.9)
Follow-up (all children)
 Total person-years accrued 2089.8
 Median months of follow-up (IQR) 31.2 (10.3–53.6)
 Median number of program visits (IQR) 30 (11–57)
 Died [n (%)] 80 (10.1)
 Lost to follow-up [n (%)] 76 (9.6)
 Transferred care [n (%)] 6 (0.8)
 Initiated cART 619 (78.4)
 Number of CD4 percentage results 3137
Follow-up (children initiating cART)
 Median weeks of follow-up prior to cART initiation (IQR) 4.0 (2.2–15.3)
 Severe immunodeficiency at cART initiation [n (%)] 454 (73.3)
 Median CD4 percentage at cART initiation (IQR) 12 (7–18)
 cART person-years accrued 1620.9
 Median months on cART (IQR) 31.3 (11.4–52.0)
 Switched cART regimen [n (%)] 110 (17.8)
 Number of CD4 percentage results during cART 2485
*

Baseline (first CD4 percentage result) was not at program enrollment for 41 of 790 children (5.2%). For these 41 children, the median number of months between enrollment and first CD4 percentage result was 2.3 (IQR, 1.1–5.3).